Case Reports
The use of high-dose intravenous immunoglobulins in Guillain-Barré syndrome
Affiliations
- PMID: 1566990
Item in Clipboard
Case Reports
The use of high-dose intravenous immunoglobulins in Guillain-Barré syndrome
Anaesthesia.
1992 Mar.
Free article
Abstract
A patient with severe Guillain-Barré syndrome responded to treatment with high-dose intravenous immunoglobulins. It is suggested, on the basis of recent case reports, that immunoglobulins may have an important rôle in the future treatment of this immune-mediated disease.
Similar articles
-
High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome.Turk J Pediatr. 1996 Jan-Mar;38(1):119-23. Turk J Pediatr. 1996. PMID: 8819632
-
[Guillain-Barré syndrome treated with high doses of immunoglobulins by the intravenous route: 4 cases].Rev Neurol (Paris). 1991;147(8-9):573-6. Rev Neurol (Paris). 1991. PMID: 1962066 French.
-
[Initial experiences in the use of intravenous immunoglobulins in Guillain-Barré-Strohl syndrome].Pediatr Med Chir. 1987 Nov-Dec;9(6):719-21. Pediatr Med Chir. 1987. PMID: 3444744 Italian.
-
High-dose intravenous immunoglobulin therapy in dysimmune neuropathies.Neurol Sci. 2002 Apr;23 Suppl 1:S25-32. doi: 10.1007/s100720200012. Neurol Sci. 2002. PMID: 12032584 Review. No abstract available.
-
[Therapy of acute polyradiculoneuritis (Guillain-Barré syndrome)].Nervenarzt. 1994 Dec;65(12):807-18. Nervenarzt. 1994. PMID: 7854501 Review. German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
